aluates Reports

$ 0.0

Automative

Global Chemotherapy-induced Nausea and Vomiting Treatment Market Research Report 2025

Published Date: February 2025

Report Code: QYRE-Auto-1X15421

Global Chemotherapy induced Nausea and Vomiting Treatment Market Insights Forecast to 2029

BUY CHAPTERS

Global Chemotherapy-induced Nausea and Vomiting Treatment Market Research Report 2025

Code: QYRE-Auto-1X15421

Report

February 2025

Pages:85

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Heron Therapeutics

Merck

Eisai Co Ltd

Mundipharma

Qilu Pharma

TEVA

Novartis

Roche

Mylan NV

Baxter

GSK

Helsinn

Southwest Pharma

Haisco

Sun Pharma

Chemotherapy-induced Nausea and Vomiting Treatment Market Size

The global market for Chemotherapy-induced Nausea and Vomiting Treatment was valued at US$ 2310 million in the year 2024 and is projected to reach a revised size of US$ 2061 million by 2031, growing at a CAGR of -1.6% during the forecast period.

Chemotherapy-induced Nausea and Vomiting Treatment Market

Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families.

The chemotherapy-induced nausea and vomiting (CINV) treatment market is driven by the increasing prevalence of cancer and the growing adoption of effective antiemetic therapies. Chemotherapy often causes nausea and vomiting, adversely affecting the quality of life of cancer patients. The rise in cancer incidence and the need for better supportive care contribute to market growth as healthcare providers and patients seek reliable CINV treatments to manage these distressing side effects. Moreover, advancements in antiemetic drug development and the introduction of combination therapies have improved treatment efficacy and patient outcomes. However, the market also faces challenges, including the individual variability in CINV response and the need for tailored treatment approaches. Additionally, addressing the cost of antiemetic drugs and ensuring accessibility to patients can pose obstacles for widespread adoption. To succeed, companies must focus on research and development to offer innovative and patient-centric CINV treatments, collaborate with oncologists to optimize treatment regimens, and address the challenges to meet the increasing demand for effective and well-tolerated antiemetic therapies for cancer patients undergoing chemotherapy.

This report aims to provide a comprehensive presentation of the global market for Chemotherapy-induced Nausea and Vomiting Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chemotherapy-induced Nausea and Vomiting Treatment.

The Chemotherapy-induced Nausea and Vomiting Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Chemotherapy-induced Nausea and Vomiting Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Chemotherapy-induced Nausea and Vomiting Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Chemotherapy-induced Nausea and Vomiting Treatment Market Report

Report Metric	Details
Report Name	Chemotherapy-induced Nausea and Vomiting Treatment Market
Accounted market size in year	US$ 2310 million
Forecasted market size in 2031	US$ 2061 million
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	5-HT3 Inhibitors NK1 Inhibitors Other
Segment by Application	Acute CINV Delayed CINV Breakthrough CINV Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Heron Therapeutics, Merck, Eisai, Mundipharma, Qilu Pharma, Teva, Novartis, Roche, Mylan, Baxter, GSK, Helsinn, Southwest Pharma, Haisco, Sun Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chemotherapy-induced Nausea and Vomiting Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

What is the Chemotherapy-induced Nausea and Vomiting Treatment Market size in 2031?

Ans: The Chemotherapy-induced Nausea and Vomiting Treatment Market size in 2031 will be US$ 2061 million.

Who are the main players in the Chemotherapy-induced Nausea and Vomiting Treatment Market report?

Ans: The main players in the Chemotherapy-induced Nausea and Vomiting Treatment Market are Heron Therapeutics, Merck, Eisai, Mundipharma, Qilu Pharma, Teva, Novartis, Roche, Mylan, Baxter, GSK, Helsinn, Southwest Pharma, Haisco, Sun Pharma

What are the Application segmentation covered in the Chemotherapy-induced Nausea and Vomiting Treatment Market report?

Ans: The Applications covered in the Chemotherapy-induced Nausea and Vomiting Treatment Market report are Acute CINV, Delayed CINV, Breakthrough CINV, Others

What are the Type segmentation covered in the Chemotherapy-induced Nausea and Vomiting Treatment Market report?

Ans: The Types covered in the Chemotherapy-induced Nausea and Vomiting Treatment Market report are 5-HT3 Inhibitors, NK1 Inhibitors, Other

Recommended Reports

Cancer Therapies

Supportive/Adjunct Care

Oncology Drug Markets

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Chemotherapy-induced Nausea and Vomiting Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 5-HT3 Inhibitors

1.2.3 NK1 Inhibitors

1.2.4 Other

1.3 Market by Application

1.3.1 Global Chemotherapy-induced Nausea and Vomiting Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Acute CINV

1.3.3 Delayed CINV

1.3.4 Breakthrough CINV

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Chemotherapy-induced Nausea and Vomiting Treatment Market Perspective (2020-2031)

2.2 Global Chemotherapy-induced Nausea and Vomiting Treatment Growth Trends by Region

2.2.1 Global Chemotherapy-induced Nausea and Vomiting Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Chemotherapy-induced Nausea and Vomiting Treatment Historic Market Size by Region (2020-2025)

2.2.3 Chemotherapy-induced Nausea and Vomiting Treatment Forecasted Market Size by Region (2026-2031)

2.3 Chemotherapy-induced Nausea and Vomiting Treatment Market Dynamics

2.3.1 Chemotherapy-induced Nausea and Vomiting Treatment Industry Trends

2.3.2 Chemotherapy-induced Nausea and Vomiting Treatment Market Drivers

2.3.3 Chemotherapy-induced Nausea and Vomiting Treatment Market Challenges

2.3.4 Chemotherapy-induced Nausea and Vomiting Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Chemotherapy-induced Nausea and Vomiting Treatment Players by Revenue

3.1.1 Global Top Chemotherapy-induced Nausea and Vomiting Treatment Players by Revenue (2020-2025)

3.1.2 Global Chemotherapy-induced Nausea and Vomiting Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Chemotherapy-induced Nausea and Vomiting Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Chemotherapy-induced Nausea and Vomiting Treatment Revenue

3.4 Global Chemotherapy-induced Nausea and Vomiting Treatment Market Concentration Ratio

3.4.1 Global Chemotherapy-induced Nausea and Vomiting Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Chemotherapy-induced Nausea and Vomiting Treatment Revenue in 2024

3.5 Global Key Players of Chemotherapy-induced Nausea and Vomiting Treatment Head office and Area Served

3.6 Global Key Players of Chemotherapy-induced Nausea and Vomiting Treatment, Product and Application

3.7 Global Key Players of Chemotherapy-induced Nausea and Vomiting Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Chemotherapy-induced Nausea and Vomiting Treatment Breakdown Data by Type

4.1 Global Chemotherapy-induced Nausea and Vomiting Treatment Historic Market Size by Type (2020-2025)

4.2 Global Chemotherapy-induced Nausea and Vomiting Treatment Forecasted Market Size by Type (2026-2031)

5 Chemotherapy-induced Nausea and Vomiting Treatment Breakdown Data by Application

5.1 Global Chemotherapy-induced Nausea and Vomiting Treatment Historic Market Size by Application (2020-2025)

5.2 Global Chemotherapy-induced Nausea and Vomiting Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Chemotherapy-induced Nausea and Vomiting Treatment Market Size (2020-2031)

6.2 North America Chemotherapy-induced Nausea and Vomiting Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Chemotherapy-induced Nausea and Vomiting Treatment Market Size by Country (2020-2025)

6.4 North America Chemotherapy-induced Nausea and Vomiting Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Chemotherapy-induced Nausea and Vomiting Treatment Market Size (2020-2031)

7.2 Europe Chemotherapy-induced Nausea and Vomiting Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Chemotherapy-induced Nausea and Vomiting Treatment Market Size by Country (2020-2025)

7.4 Europe Chemotherapy-induced Nausea and Vomiting Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Chemotherapy-induced Nausea and Vomiting Treatment Market Size (2020-2031)

8.2 Asia-Pacific Chemotherapy-induced Nausea and Vomiting Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Chemotherapy-induced Nausea and Vomiting Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Chemotherapy-induced Nausea and Vomiting Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Chemotherapy-induced Nausea and Vomiting Treatment Market Size (2020-2031)

9.2 Latin America Chemotherapy-induced Nausea and Vomiting Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Chemotherapy-induced Nausea and Vomiting Treatment Market Size by Country (2020-2025)

9.4 Latin America Chemotherapy-induced Nausea and Vomiting Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Chemotherapy-induced Nausea and Vomiting Treatment Market Size (2020-2031)

10.2 Middle East & Africa Chemotherapy-induced Nausea and Vomiting Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Chemotherapy-induced Nausea and Vomiting Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Chemotherapy-induced Nausea and Vomiting Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Heron Therapeutics

11.1.1 Heron Therapeutics Company Details

11.1.2 Heron Therapeutics Business Overview

11.1.3 Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Treatment Introduction

11.1.4 Heron Therapeutics Revenue in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025)

11.1.5 Heron Therapeutics Recent Development

11.2 Merck

11.2.1 Merck Company Details

11.2.2 Merck Business Overview

11.2.3 Merck Chemotherapy-induced Nausea and Vomiting Treatment Introduction

11.2.4 Merck Revenue in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025)

11.2.5 Merck Recent Development

11.3 Eisai

11.3.1 Eisai Company Details

11.3.2 Eisai Business Overview

11.3.3 Eisai Chemotherapy-induced Nausea and Vomiting Treatment Introduction

11.3.4 Eisai Revenue in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025)

11.3.5 Eisai Recent Development

11.4 Mundipharma

11.4.1 Mundipharma Company Details

11.4.2 Mundipharma Business Overview

11.4.3 Mundipharma Chemotherapy-induced Nausea and Vomiting Treatment Introduction

11.4.4 Mundipharma Revenue in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025)

11.4.5 Mundipharma Recent Development

11.5 Qilu Pharma

11.5.1 Qilu Pharma Company Details

11.5.2 Qilu Pharma Business Overview

11.5.3 Qilu Pharma Chemotherapy-induced Nausea and Vomiting Treatment Introduction

11.5.4 Qilu Pharma Revenue in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025)

11.5.5 Qilu Pharma Recent Development

11.6 Teva

11.6.1 Teva Company Details

11.6.2 Teva Business Overview

11.6.3 Teva Chemotherapy-induced Nausea and Vomiting Treatment Introduction

11.6.4 Teva Revenue in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025)

11.6.5 Teva Recent Development

11.7 Novartis

11.7.1 Novartis Company Details

11.7.2 Novartis Business Overview

11.7.3 Novartis Chemotherapy-induced Nausea and Vomiting Treatment Introduction

11.7.4 Novartis Revenue in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025)

11.7.5 Novartis Recent Development

11.8 Roche

11.8.1 Roche Company Details

11.8.2 Roche Business Overview

11.8.3 Roche Chemotherapy-induced Nausea and Vomiting Treatment Introduction

11.8.4 Roche Revenue in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025)

11.8.5 Roche Recent Development

11.9 Mylan

11.9.1 Mylan Company Details

11.9.2 Mylan Business Overview

11.9.3 Mylan Chemotherapy-induced Nausea and Vomiting Treatment Introduction

11.9.4 Mylan Revenue in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025)

11.9.5 Mylan Recent Development

11.10 Baxter

11.10.1 Baxter Company Details

11.10.2 Baxter Business Overview

11.10.3 Baxter Chemotherapy-induced Nausea and Vomiting Treatment Introduction

11.10.4 Baxter Revenue in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025)

11.10.5 Baxter Recent Development

11.11 GSK

11.11.1 GSK Company Details

11.11.2 GSK Business Overview

11.11.3 GSK Chemotherapy-induced Nausea and Vomiting Treatment Introduction

11.11.4 GSK Revenue in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025)

11.11.5 GSK Recent Development

11.12 Helsinn

11.12.1 Helsinn Company Details

11.12.2 Helsinn Business Overview

11.12.3 Helsinn Chemotherapy-induced Nausea and Vomiting Treatment Introduction

11.12.4 Helsinn Revenue in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025)

11.12.5 Helsinn Recent Development

11.13 Southwest Pharma

11.13.1 Southwest Pharma Company Details

11.13.2 Southwest Pharma Business Overview

11.13.3 Southwest Pharma Chemotherapy-induced Nausea and Vomiting Treatment Introduction

11.13.4 Southwest Pharma Revenue in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025)

11.13.5 Southwest Pharma Recent Development

11.14 Haisco

11.14.1 Haisco Company Details

11.14.2 Haisco Business Overview

11.14.3 Haisco Chemotherapy-induced Nausea and Vomiting Treatment Introduction

11.14.4 Haisco Revenue in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025)

11.14.5 Haisco Recent Development

11.15 Sun Pharma

11.15.1 Sun Pharma Company Details

11.15.2 Sun Pharma Business Overview

11.15.3 Sun Pharma Chemotherapy-induced Nausea and Vomiting Treatment Introduction

11.15.4 Sun Pharma Revenue in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025)

11.15.5 Sun Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Heron Therapeutics

Merck

Eisai Co Ltd

Mundipharma

Qilu Pharma

TEVA

Novartis

Roche

Mylan NV

Baxter

GSK

Helsinn

Southwest Pharma

Haisco

Sun Pharma

List of Tables

Table 1. Global Chemotherapy-induced Nausea and Vomiting Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of 5-HT3 Inhibitors

Table 3. Key Players of NK1 Inhibitors

Table 4. Key Players of Other

Table 5. Global Chemotherapy-induced Nausea and Vomiting Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Chemotherapy-induced Nausea and Vomiting Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Chemotherapy-induced Nausea and Vomiting Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Chemotherapy-induced Nausea and Vomiting Treatment Market Share by Region (2020-2025)

Table 9. Global Chemotherapy-induced Nausea and Vomiting Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Chemotherapy-induced Nausea and Vomiting Treatment Market Share by Region (2026-2031)

Table 11. Chemotherapy-induced Nausea and Vomiting Treatment Market Trends

Table 12. Chemotherapy-induced Nausea and Vomiting Treatment Market Drivers

Table 13. Chemotherapy-induced Nausea and Vomiting Treatment Market Challenges

Table 14. Chemotherapy-induced Nausea and Vomiting Treatment Market Restraints

Table 15. Global Chemotherapy-induced Nausea and Vomiting Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Chemotherapy-induced Nausea and Vomiting Treatment Market Share by Players (2020-2025)

Table 17. Global Top Chemotherapy-induced Nausea and Vomiting Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemotherapy-induced Nausea and Vomiting Treatment as of 2024)

Table 18. Ranking of Global Top Chemotherapy-induced Nausea and Vomiting Treatment Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Chemotherapy-induced Nausea and Vomiting Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Chemotherapy-induced Nausea and Vomiting Treatment, Headquarters and Area Served

Table 21. Global Key Players of Chemotherapy-induced Nausea and Vomiting Treatment, Product and Application

Table 22. Global Key Players of Chemotherapy-induced Nausea and Vomiting Treatment, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Chemotherapy-induced Nausea and Vomiting Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Chemotherapy-induced Nausea and Vomiting Treatment Revenue Market Share by Type (2020-2025)

Table 26. Global Chemotherapy-induced Nausea and Vomiting Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Chemotherapy-induced Nausea and Vomiting Treatment Revenue Market Share by Type (2026-2031)

Table 28. Global Chemotherapy-induced Nausea and Vomiting Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Chemotherapy-induced Nausea and Vomiting Treatment Revenue Market Share by Application (2020-2025)

Table 30. Global Chemotherapy-induced Nausea and Vomiting Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Chemotherapy-induced Nausea and Vomiting Treatment Revenue Market Share by Application (2026-2031)

Table 32. North America Chemotherapy-induced Nausea and Vomiting Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Chemotherapy-induced Nausea and Vomiting Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Chemotherapy-induced Nausea and Vomiting Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Chemotherapy-induced Nausea and Vomiting Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Chemotherapy-induced Nausea and Vomiting Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Chemotherapy-induced Nausea and Vomiting Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Chemotherapy-induced Nausea and Vomiting Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Chemotherapy-induced Nausea and Vomiting Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Chemotherapy-induced Nausea and Vomiting Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Chemotherapy-induced Nausea and Vomiting Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Chemotherapy-induced Nausea and Vomiting Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Chemotherapy-induced Nausea and Vomiting Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Chemotherapy-induced Nausea and Vomiting Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Chemotherapy-induced Nausea and Vomiting Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Chemotherapy-induced Nausea and Vomiting Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 47. Heron Therapeutics Company Details

Table 48. Heron Therapeutics Business Overview

Table 49. Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Treatment Product

Table 50. Heron Therapeutics Revenue in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025) & (US$ Million)

Table 51. Heron Therapeutics Recent Development

Table 52. Merck Company Details

Table 53. Merck Business Overview

Table 54. Merck Chemotherapy-induced Nausea and Vomiting Treatment Product

Table 55. Merck Revenue in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025) & (US$ Million)

Table 56. Merck Recent Development

Table 57. Eisai Company Details

Table 58. Eisai Business Overview

Table 59. Eisai Chemotherapy-induced Nausea and Vomiting Treatment Product

Table 60. Eisai Revenue in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025) & (US$ Million)

Table 61. Eisai Recent Development

Table 62. Mundipharma Company Details

Table 63. Mundipharma Business Overview

Table 64. Mundipharma Chemotherapy-induced Nausea and Vomiting Treatment Product

Table 65. Mundipharma Revenue in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025) & (US$ Million)

Table 66. Mundipharma Recent Development

Table 67. Qilu Pharma Company Details

Table 68. Qilu Pharma Business Overview

Table 69. Qilu Pharma Chemotherapy-induced Nausea and Vomiting Treatment Product

Table 70. Qilu Pharma Revenue in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025) & (US$ Million)

Table 71. Qilu Pharma Recent Development

Table 72. Teva Company Details

Table 73. Teva Business Overview

Table 74. Teva Chemotherapy-induced Nausea and Vomiting Treatment Product

Table 75. Teva Revenue in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025) & (US$ Million)

Table 76. Teva Recent Development

Table 77. Novartis Company Details

Table 78. Novartis Business Overview

Table 79. Novartis Chemotherapy-induced Nausea and Vomiting Treatment Product

Table 80. Novartis Revenue in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025) & (US$ Million)

Table 81. Novartis Recent Development

Table 82. Roche Company Details

Table 83. Roche Business Overview

Table 84. Roche Chemotherapy-induced Nausea and Vomiting Treatment Product

Table 85. Roche Revenue in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025) & (US$ Million)

Table 86. Roche Recent Development

Table 87. Mylan Company Details

Table 88. Mylan Business Overview

Table 89. Mylan Chemotherapy-induced Nausea and Vomiting Treatment Product

Table 90. Mylan Revenue in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025) & (US$ Million)

Table 91. Mylan Recent Development

Table 92. Baxter Company Details

Table 93. Baxter Business Overview

Table 94. Baxter Chemotherapy-induced Nausea and Vomiting Treatment Product

Table 95. Baxter Revenue in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025) & (US$ Million)

Table 96. Baxter Recent Development

Table 97. GSK Company Details

Table 98. GSK Business Overview

Table 99. GSK Chemotherapy-induced Nausea and Vomiting Treatment Product

Table 100. GSK Revenue in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025) & (US$ Million)

Table 101. GSK Recent Development

Table 102. Helsinn Company Details

Table 103. Helsinn Business Overview

Table 104. Helsinn Chemotherapy-induced Nausea and Vomiting Treatment Product

Table 105. Helsinn Revenue in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025) & (US$ Million)

Table 106. Helsinn Recent Development

Table 107. Southwest Pharma Company Details

Table 108. Southwest Pharma Business Overview

Table 109. Southwest Pharma Chemotherapy-induced Nausea and Vomiting Treatment Product

Table 110. Southwest Pharma Revenue in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025) & (US$ Million)

Table 111. Southwest Pharma Recent Development

Table 112. Haisco Company Details

Table 113. Haisco Business Overview

Table 114. Haisco Chemotherapy-induced Nausea and Vomiting Treatment Product

Table 115. Haisco Revenue in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025) & (US$ Million)

Table 116. Haisco Recent Development

Table 117. Sun Pharma Company Details

Table 118. Sun Pharma Business Overview

Table 119. Sun Pharma Chemotherapy-induced Nausea and Vomiting Treatment Product

Table 120. Sun Pharma Revenue in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025) & (US$ Million)

Table 121. Sun Pharma Recent Development

Table 122. Research Programs/Design for This Report

Table 123. Key Data Information from Secondary Sources

Table 124. Key Data Information from Primary Sources

Table 125. Authors List of This Report

List of Figures

Figure 1. Chemotherapy-induced Nausea and Vomiting Treatment Picture

Figure 2. Global Chemotherapy-induced Nausea and Vomiting Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Chemotherapy-induced Nausea and Vomiting Treatment Market Share by Type: 2024 VS 2031

Figure 4. 5-HT3 Inhibitors Features

Figure 5. NK1 Inhibitors Features

Figure 6. Other Features

Figure 7. Global Chemotherapy-induced Nausea and Vomiting Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Chemotherapy-induced Nausea and Vomiting Treatment Market Share by Application: 2024 VS 2031

Figure 9. Acute CINV Case Studies

Figure 10. Delayed CINV Case Studies

Figure 11. Breakthrough CINV Case Studies

Figure 12. Others Case Studies

Figure 13. Chemotherapy-induced Nausea and Vomiting Treatment Report Years Considered

Figure 14. Global Chemotherapy-induced Nausea and Vomiting Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Chemotherapy-induced Nausea and Vomiting Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Chemotherapy-induced Nausea and Vomiting Treatment Market Share by Region: 2024 VS 2031

Figure 17. Global Chemotherapy-induced Nausea and Vomiting Treatment Market Share by Players in 2024

Figure 18. Global Top Chemotherapy-induced Nausea and Vomiting Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemotherapy-induced Nausea and Vomiting Treatment as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Chemotherapy-induced Nausea and Vomiting Treatment Revenue in 2024

Figure 20. North America Chemotherapy-induced Nausea and Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Chemotherapy-induced Nausea and Vomiting Treatment Market Share by Country (2020-2031)

Figure 22. United States Chemotherapy-induced Nausea and Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Chemotherapy-induced Nausea and Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Chemotherapy-induced Nausea and Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Chemotherapy-induced Nausea and Vomiting Treatment Market Share by Country (2020-2031)

Figure 26. Germany Chemotherapy-induced Nausea and Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Chemotherapy-induced Nausea and Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Chemotherapy-induced Nausea and Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Chemotherapy-induced Nausea and Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Chemotherapy-induced Nausea and Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Chemotherapy-induced Nausea and Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Chemotherapy-induced Nausea and Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Chemotherapy-induced Nausea and Vomiting Treatment Market Share by Region (2020-2031)

Figure 34. China Chemotherapy-induced Nausea and Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Chemotherapy-induced Nausea and Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Chemotherapy-induced Nausea and Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Chemotherapy-induced Nausea and Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Chemotherapy-induced Nausea and Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Chemotherapy-induced Nausea and Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Chemotherapy-induced Nausea and Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Chemotherapy-induced Nausea and Vomiting Treatment Market Share by Country (2020-2031)

Figure 42. Mexico Chemotherapy-induced Nausea and Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Chemotherapy-induced Nausea and Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Chemotherapy-induced Nausea and Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Chemotherapy-induced Nausea and Vomiting Treatment Market Share by Country (2020-2031)

Figure 46. Turkey Chemotherapy-induced Nausea and Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Chemotherapy-induced Nausea and Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Chemotherapy-induced Nausea and Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Heron Therapeutics Revenue Growth Rate in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025)

Figure 50. Merck Revenue Growth Rate in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025)

Figure 51. Eisai Revenue Growth Rate in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025)

Figure 52. Mundipharma Revenue Growth Rate in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025)

Figure 53. Qilu Pharma Revenue Growth Rate in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025)

Figure 54. Teva Revenue Growth Rate in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025)

Figure 55. Novartis Revenue Growth Rate in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025)

Figure 56. Roche Revenue Growth Rate in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025)

Figure 57. Mylan Revenue Growth Rate in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025)

Figure 58. Baxter Revenue Growth Rate in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025)

Figure 59. GSK Revenue Growth Rate in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025)

Figure 60. Helsinn Revenue Growth Rate in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025)

Figure 61. Southwest Pharma Revenue Growth Rate in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025)

Figure 62. Haisco Revenue Growth Rate in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025)

Figure 63. Sun Pharma Revenue Growth Rate in Chemotherapy-induced Nausea and Vomiting Treatment Business (2020-2025)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Chemotherapy Induced Nausea and Vomiting CINV Drugs Market Insights Forecast to 2030

Global Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market Insights Forecast to 2030

Chemotherapy induced Nausea and Vomiting Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antiemetics for Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chemotherapy Induced Neutropenia CIN Drug Market Research Report 2025

Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Insights Forecast to 2030

Global Chemotherapy Induced Oral Mucositis Treatment Market Research Report 2024

Antiemetic Patch Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chemotherapy Induced Myelosuppression Treatments Market Research Report 2024

Global Nausea And Vomiting Treatment Market Insights Forecast to 2030

Global Electronic Antiemetic Device Market Research Report 2024

Global Ondansetron Hydrochloride Injection Market Research Report 2024

Global Medical Electronic Antiemetic Device Market Research Report 2024

Global Household Electronic Antiemetic Device Market Research Report 2024

Postoperative Nausea and Vomiting Management Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Wearable Drug Induced Antiemetic Device Market Research Report 2024

Global Chemotherapy Drug Market Insights Forecast to 2030

Cancer Therapeutics and Supportive Care Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Ramosetron Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions